The largest database of trusted experimental protocols

Mouse anti human cd31

Manufactured by Agilent Technologies
Sourced in United Kingdom, Denmark

The Mouse anti-human CD31 is a laboratory reagent used for the identification and characterization of cells expressing the CD31 antigen, also known as PECAM-1 (Platelet Endothelial Cell Adhesion Molecule-1). CD31 is a transmembrane glycoprotein expressed on the surface of endothelial cells, platelets, and certain leukocyte subsets. This antibody can be used in various immunological techniques, such as flow cytometry and immunohistochemistry, to detect and analyze CD31-positive cells.

Automatically generated - may contain errors

22 protocols using mouse anti human cd31

1

Immunofluorescent Staining of Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunofluorescent double staining analysis was performed on ECDHCC and HUVECs which were seeded on sterile slice cover slips in six well plates overnight. Following several washes with PBS, cells were fixed with 4% paraformaldehyde for 30 min at room temperature and permeabilized with 0.1% Triton X-100 in PBS for 5 min. The cells were overlaid with 5% BSA for 30 min, rinsed with PBS and incubated with a mixture of rabbit-anti-human CD105 (1:20 dilutions; Abcam, Cambridge, UK) and mouse-anti-human CD31 (1:40 dilutions; DAKO) or a mixture of rabbit-anti-human CD105 (1:20 dilutions) and mouse-anti-human VEGFR-2 (1:200 dilutions) (both from Abcam) overnight at 4°C. Cells were washed three times with PBS and then incubated with Alex-488-conjugated donkey-anti-rabbit IgG and Dylight-649-conjugated donkey-anti-mouse IgG (1:200 dilutions, Jackson ImmunoResearch, West Grove, PA, USA) secondary antibodies. The slices were incubated at 37°C for 45 min, and nuclear staining was performed with DAPI. Coverslips were mounted with fluorescent mounting medium onto glass slides, and examined with confocal microscopy (Leica TCS SP5II; Leica Microsystems, Wetzlar, Germany). Images were collected from at least three independent experiments and processed for presentation in figures using Adobe Photoshop 6.0 (Adobe Systems, San Jose, CA, USA).
+ Open protocol
+ Expand
2

Immunofluorescent and Immunohistochemical Analysis of LOX-1 in Sickle Cell Disease

Check if the same lab product or an alternative is used in the 5 most similar protocols
For immunofluorescent staining: cultured HBMVECs were incubated with RBCs (isolated from SCD patients or normal controls) for 6 h, washed 3 times with medium, fixed with 4% paraformaldehyde for 20 min at room temperature, blocked with 20% donkey serum for 30 min at RT, then incubated with primary antibodies mouse anti-human CD31(pre-diluted, Dako) and chicken anti-human LOX-1(10 μg/ml, HUC52) overnight at 4 °C, followed by incubation with secondary antibodies Cy3-donkey anti-mouse and FITC-donkey anti-chicken (1:500, Jackson ImmunoResearch Lab) for 1 h at RT. Nuclei were stained with DAPI and images were acquired using a Keyence microscope. Immunohistochemistry staining of LOX-1 was performed on formalin-fixed paraffin-embedded human tissues collected from an autopsy of a sickle cell disease patient who died in sickle cell crisis and a non-sickle cell disease control autopsy. The slides were immuno-stained after heat-induced antigen retrieval using rabbit polyclonal antibody to human LOX-1 (5 μg/ml, Novus Biologicals CO, USA) as previous described [18 (link)].
+ Open protocol
+ Expand
3

Immunofluorescence Staining of Vascular Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunostaining was performed using the following primary antibodies: rabbit anti-human VWF (1:150; Dako), mouse anti-Human TSP (1:75, Laboratory Vision/ Neomarkers) rat anti-mouse CD31 (1:50; BD Biosciences), rat anti-mouse GPIbα/CD42 (1:100; EMFRET Analytics), mouse anti-human CD31 (1:50; Dako), and rabbit anti-mouse vascular endothelial growth factor-A (VEGF-A) (1:150; Santa Cruz). Following secondary antibodies were used: fluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit IgG (1:200; BD Pharmingen), Alexa 555-conjugated goat anti-rat IgG (1:200; Invitrogen). Nuclei were counterstained with DAPI (1:1000). Fluorescence images were acquired with a Zeiss Axiovert 200 microscope and were analyzed using AxioVision v4.8 (Zeiss) and ImageJ v1.47c.
+ Open protocol
+ Expand
4

Immunohistochemical Analysis of CD31 Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
CAM sections were deparaffinized and rehydrated in an MICROM HMS740 automatic stainer (MICROM, Walldorf, Germany). Immunohistochemical analysis was performed using a streptavidin–biotin peroxidase complex system. Briefly, after rehydration, slides were subjected to heat-induced antigen-retrieval with 10 mM citrate buffer at pH = 6 for 2 min at 98 °C. The slides were washed with PBS and then incubated with 3% hydrogen peroxide for 10 min to inactivate endogenous peroxidases. Another washing step was performed, and nonspecific binding was blocked with a 2.5% (v/v) horse serum (Vector Labs, Newark, CA, USA) for 30 min, before overnight incubation at 4 °C with mouse anti-human CD31 (1:30) (Dako, Cambridge, UK). Sections were washed with 0.1% tween in PBS and incubated with a secondary biotinylated antibody (Vector Labs, Newark, CA, USA) for 20 min. After thoroughly washed with 0.1% tween in PBS, samples were incubated with streptavidin-HRP (Vector Labs, Newark, CA, USA) for 20 min, followed by 3,3′diaminobenzidine (DAB) incubation (Vector Labs, Newark, CA, USA). Finally, all sections were counterstained with Mayer’s hematoxylin, dehydrated and mounted with resinous mounting medium Entellan® (Merck, Darmstadt, Germany).
+ Open protocol
+ Expand
5

Immunostaining of Vascular Hydrogels

Check if the same lab product or an alternative is used in the 5 most similar protocols
Formalin (Sigma Aldrich, St. Louis, MO) was used to fix Perivascular-only and Tri-Culture hydrogels. Cells were subsequently permeabilized with 0.5% Tween 20 (Thermo Fisher Scientific, Waltham, MA) in PBS, and blocked with 2% BSA (Sigma Aldrich, St. Louis, MO) and 0.1% Tween 20 in PBS. Hydrogels were stained using mouse anti-human CD31 (1:200, Dako, Denmark), rabbit anti-human ANG2 (1:100, Thermo Fisher Scientific, Waltham, MA), and/or goat anti-human VEGF (1:30, Novus Biologicals, Littleton, CO) as primary antibodies, and chicken anti-mouse Alexa Fluor 488 and donkey anti-rabbit Alexa Fluor 555 or donkey anti-goat Alexa Fluor 555 (1:500, Thermo Fisher Scientific, Waltham, MA) as secondary antibodies. Z-stacks were imaged using a DMi8 Yokogawa W1 spinning disk confocal microscope with a Hamamatsu EM-CCD digital camera (Leica Microsystems, Buffalo Grove, IL).
+ Open protocol
+ Expand
6

Fluorescent Visualization of 3D Cell Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
Each of the seeded scaffolds was stained using fluorescent antibodies for microscopy. Scaffolds seeded with human dermal fibroblasts were stained with 1:6 phalloidin (Alexa Fluor 488, Thermo Fisher) and scaffolds seeded with human dermal endothelial cells were stained with 1:250 mouse anti-human CD31 (Dako) and 1:1000 rabbit anti-human vWF (Dako). Secondary staining was done using goat anti-mouse (Alexa Fluor 488, Thermo Fisher) and goat anti-rabbit (Alexa Fluor 568, Thermo Fischer). Scaffolds seeded with mesenchymal stem cells were not stained, since they expressed GFP. Z-stacks were taken to visualize cell migration through the scaffold by wide-field imaging at 20× magnification. Images were deconvoluted using AutoQuant X3 (Media Cybernetics) and visualised using Bitplane (Imaris software, Version 9.1).
+ Open protocol
+ Expand
7

Endothelial Cell Identification for Laser Capture Microdissection

Check if the same lab product or an alternative is used in the 5 most similar protocols
For endothelial cell identification before LCM, cells were seeded into DuplexDish 35 (Carl Zeiss AG, Oberkochen, Germany), a culture dish especially adapted for non-contact LCM. Cells were fixed with 4% PFA for 10 min and then blocked with 5% goat serum (Jackson ImmunoResearch Laboratories, West Grove, PA) in 1× PBS for 30 min. Then cells were incubated with primary antibodies diluted in 5% goat serum in 1× PBS overnight at 4 °C at the following concentrations: mouse anti-human CD31 (Dako, Glostrup, Denmark) at 1:50 dilution or mouse anti-human Von Willebrand factor (vWF) antibody (Dako, Glostrup, Denmark) at 1:200 dilution, followed by incubation with 1:400 diluted Alexa Fluor 488-conjugated goat anti-mouse IgG (Molecular probes, Eugene, OR) for 1 h at RT. Then the cell nucleus was stained by either 4′,6-diamidino-2-phenylindole (DAPI) in Vectashield Hard Set Mounting Medium (Vector Laboratories, Burlinggame, CA) or 1:100 diluted propidium iodide (Abcam, San Francisco, CA). Both CD31 and vWF antibodies for EC immunofluorescent staining were tested and got positive signal at the beginning of this study. Because CD31 gave better cell surface signal which is easier to identify than the cytosol vWF signal under microscopy, we used CD31 as the identifying EC marker for LCM throughout this study.
+ Open protocol
+ Expand
8

Identification of HUVECs in Tissue Aggregates

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD31 staining was used to identify the presence and spatial distribution of HUVECs located in and/or around the aggregates. The sample sections were incubated for 30 minutes in 10% FBS (diluted in phosphate buffered saline (PBS)) to prevent non-specific background staining (blocking). The samples were then incubated for 1 hour in the primary antibody, mouse anti-human CD31 (Dako, UK), at a dilution of 1:20 in PBS. The samples were then incubated for 1 hour in the secondary antibody, alexa-fluor 594-conjugated goat anti-mouse IgG1 (Life Technologies, UK), diluted 1:200 in PBS. DAPI staining was carried out using a DAPI-conjugated mounting medium without further adjustment. The samples were then ready for imaging.
+ Open protocol
+ Expand
9

Purification and Application of LYVE-1 Antibody

Check if the same lab product or an alternative is used in the 5 most similar protocols
Monoclonal mouse anti-human LYVE-1 (LYVE-1 mAb) was affinity-purified from hybridoma cultures as previously described in (Nightingale et al., 2009 (link); Johnson et al., 2007 (link)). Mouse anti-human CD31 was purchased from Dako (#M0823, Dako, UK) and mouse anti-human CD44 were from IGBRL (#9430, IGBRL, UK). Alexa Fluor® 488 Mouse anti-human CD31 (#303109) and Alexa Fluor® 488 rat anti-human CD44 (#103015) was purchased from Biolegend, USA. Secondary antibody goat anti-mouse Oregon Green® 488 was purchased from Life Technologies, UK (#06380). All antibodies were used at a concentration of 10 µg/ml unless otherwise stated.
+ Open protocol
+ Expand
10

Immunofluorescent Labeling of Endothelial Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were fixed in 4% paraformaldehyde and permeablised with 0.1% TritonX-100 at room temperature. Cells were blocked with donkey serum for 30 minutes to prevent non-specific binding. Cells were then incubated with 1% BSA in PBS containing the following primary antibody dilutions for 1 hr at room temperature; mouse anti-human CD31 (1:300, Dako, Clone JCT0A), mouse anti-human vWF (1:100, Dako), rabbit anti-human VE-Cadherin (1:200, Cell Signaling Technology), rabbit anti-human VEGFR-2 (1:100, Cell Signaling), mouse anti-human eNOS (1:100, BD Biosciences). Following incubation with primary antibody, cells were incubated with species appropriate, fluorophore tagged secondary antibodies for 45 minutes at room temperature. Cells were mounted with Prolong Gold Antifade Reagent (Invitrogen) and visualised using a LSM 880 confocal microscope (Zeiss).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!